the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Ethiopia’s Lemma and Kenya’s Obiri win Boston Marathon

BOSTON: Sisay Lemma of Ethiopia has won the Boston Marathon for the first time in his career, running the course in 2:06:17 hours on Monday, the tenth fastest time in the race’s history, reported German news agency dpa.

In the women’s race, Kenya’s Hellen Obiri defended her title, completing the course in 2:22:37 hours. Obiri is the first woman since 2005 to win the Boston Marathon twice in a row. Her Kenyan compatriot Sharon Lokedi came in second place, seconds later, followed by two-time Boston winner Edna Kiplagat (2:23:21) in third place, also from Kenya.

Lemma’s best result in his four previous starts was a 30th place, and he did not complete the course twice.

Defending champion Evans Chebet, who won the marathon in the last two years, came in third place with a time of 2:07:22 hours.

Lemma, 33, who won the London Marathon in 2021, set a fast pace from the start and ran most of the course alone. In the first half, he was 99 seconds faster than Geoffrey Mutai in his 2011 course record of 2:03:02 hours.

Lemma’s compatriot Mohames Esa closed the gap in the final kilometres and finished second, 41 seconds behind. It was the first victory for an Ethiopian in Boston since 2016. – Bernama, dpa

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings